COMP <GO>
HLF vs CAH // ENTERPRISE SCALE & MARKET CAP
Herbalife Ltd. (NYSE) VS. Cardinal Health Inc. (NYSE) • 15-METRIC TALLY: HLF 8
— CAH 4
▲ ENTERPRISE SCALE & MARKET CAP LEADER: CAH
LAST: $13.05 (+0.93%) • MKT CAP: $1.36B
market-cap
$1.36B
LAST: $250.48 (-0.24%) • MKT CAP: $58.14B
market-cap
$58.14B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HLF VS. CAH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HLF | CAH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 77.90% | 3.70% | +74.20 | HLF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 34.40% | 29.70% | +4.70 | HLF | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.4x | 24.5x | -19.10 | HLF | /valuation <GO> |
| Free Cash Flow Yield | 18.66% | 3.18% | +15.48 | HLF | /fcf-yield <GO> |
| Operating Margin | 9.50% | 1.00% | +8.50 | HLF | /operating-margins <GO> |
| Net Profit Margin | 4.50% | 0.70% | +3.80 | HLF | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | -1.90% | +2.80 | HLF | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.85% | -0.85 | CAH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.39 | 5.16 | -2.77 | CAH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 59.1 | -13.40 | CAH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.90 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 5.5x | 34.6x | -29.10 | HLF | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $1.36B | $58.14B | -$56.79B | CAH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HLF REV | CAH REV | HLF GROSS % | CAH GROSS % | HLF FCF | CAH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.04B | $222.58B | 77.9% | 3.7% | $252.9M | $1.85B |
| FY 2024 | $4.99B | $226.83B | 77.9% | 3.3% | $163.4M | $3.25B |
| FY 2023 | $5.06B | $204.98B | — | — | $357.5M | -$6.38B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HLF // BETA —
CAH // BETA 0.90